Thriving Again review

What it is

Thriving Again is a US telehealth platform positioned around men's health and optimization, organised into five verticals: Weight Loss (compounded GLP-1 medication shipped as pre-filled syringes), Hormones (injectable testosterone cypionate, an oral testosterone, enclomiphene and an oral-testosterone-plus-enclomiphene combination), Longevity (BPC-157 and ipamorelin), Hair (finasteride and minoxidil) and Sexual Health (sildenafil, tadalafil). It advertises more than 500 board-certified, state-licensed providers across all 50 states, at-home lab testing, 24/7 clinical messaging and a free assessment quiz, and it carries the FDA compounded-medication disclaimer.

How it works

Quiz-first and asynchronous, with separate intake funnels for testosterone, weight loss, longevity and sexual health rather than one generic form — which usually means better-targeted questions. The part that distinguishes it is the lab discipline: each testosterone option states "Requires bloodwork" on the option card itself, and the site describes sending an at-home lab kit so you can check your levels from home with results in about three days. For an open-ended hormone prescription that is the correct sequence, and it is not universal on this board. Its stated support model is 24/7 messaging with a clinical team plus metabolic labs to track progress. What it does not publish is anything that would let you verify the operation: no compounding pharmacy, no medical group, no individual clinician and no medical director is named, no state list is enumerated behind the all-50-states claim, and no LegitScript certification is surfaced. So you are being asked to trust a scale claim — 500+ providers, 50 states, 10,000+ members — with no checkable anchor behind it. The lab requirement is real; the corporate transparency is not there yet.

Pricing transparency

The weakest part of an otherwise reasonable proposition. One number appears on the site — "hormone & peptide protocols built for men from $149/mo" — and it is asked to represent testosterone, BPC-157 and ipamorelin simultaneously. No molecule has its own price. No dose, vial size or supply length is published for any peptide. The lab kit's cost, and whether it is included or billed separately, is not stated. Nor is it stated whether the ongoing monitoring labs that testosterone therapy requires are covered. Because "from $149" describes a platform rather than a product, we publish no floor on either board and quote the figure only as what it is: a floor for the cheapest thing in a wide catalog, which is unlikely to be the thing you want. Before starting, ask three questions in writing — what your specific protocol costs per month, what the lab kit costs and how often it is repeated, and whether the price changes as a provider titrates a dose. On the GLP-1 side, its own record notes that no dose-specific pricing is published either, so this is a platform-wide habit rather than an oversight on one page.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The site carries the FDA compounding disclaimer and describes prescriptions written by board-certified, state-licensed providers with medication compounded by a licensed pharmacy, which it does not name; compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On evidence the catalog splits sharply. Testosterone replacement is the one therapy here with a large randomised safety base behind it, and it still requires ongoing haematocrit, PSA and testosterone monitoring — the site requires baseline bloodwork, which is right, but does not commit to a monitoring schedule. Enclomiphene is a selective oestrogen receptor modulator used off-label to raise endogenous testosterone; it has real human data on testosterone levels and much thinner data on symptoms and long-term safety. BPC-157 and ipamorelin sit at the far end: BPC-157 has no controlled human outcome trials at all and its tendon and gut-repair reputation rests on rodent work, while ipamorelin is a growth-hormone secretagogue with a real mechanism and essentially no long-term human outcome data. Individual results vary.

Pros and watch-outs

The evidence behind what Thriving Again prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

• TRT and Hematocrit: Why Testosterone Thickens the Blood, and What to Do About It

  Erythrocytosis is the most common lab change on testosterone therapy — predictable, route-dependent, and manageable with monitoring.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How Thriving Again compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TKTRT Kingdom

  People comfortable with a multi-month minimum and a separate recurring lab fee

  See TRT Kingdom →
• TWTonik Wellness

  People who want named pharmacies and a video visit, and will check stock before planning around a price

  See Tonik Wellness →
• VVValhalla Vitality

  People who want several NAD⁺ routes on one menu and will register before comparing prices

  See Valhalla Vitality →